Consuming a buttermilk drink containing lutein-enriched egg yolk daily for 1 year increased plasma lutein but did not affect serum lipid or lipoprotein concentrations in adults with early signs of age-related macular degeneration

Journal of Nutrition

Volumn 144, Issue 9, 2014, Pages 1370-1377

  van der Made, Sanne M ^a   Kelly, Elton R ^b   Berendschot, Tos T J M ^b   Kijlstra, Aize ^b   Lu¨tjohann, Dieter ^c   Plat, Jogchum ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CAMPESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LATHOSTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; XANTHOPHYLL; ZEAXANTHIN; CHOLESTEROL; CHOLESTEROL INTAKE; PHYTOSTEROL;

ADULT; AGE RELATED MACULAR DEGENERATION; ARTICLE; BEVERAGE; BUTTERMILK DRINK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EGG YOLK; FEMALE; FOLLOW UP; FOOD INTAKE; GENOTYPE; HUMAN; INTERVENTION STUDY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; VISION; VITAMIN BLOOD LEVEL; AGED; ANALOGS AND DERIVATIVES; BLOOD; CARDIOVASCULAR DISEASES; CHEMISTRY; CHOLESTEROL INTAKE; DAIRY PRODUCT; DIET; DIET SUPPLEMENTATION; DISEASE COURSE; INTESTINE ABSORPTION; MACULAR DEGENERATION; METABOLISM; MIDDLE AGED; TIME;

AGED; BEVERAGES; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CULTURED MILK PRODUCTS; DIET; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; EGG YOLK; FEMALE; HUMANS; INTESTINAL ABSORPTION; LUTEIN; MACULAR DEGENERATION; MALE; MIDDLE AGED; PHYTOSTEROLS; TIME FACTORS;

EID: 84906898896     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.114.195503     Document Type: Article

References (44)

1. Applegate E. Introduction: nutritional and functional roles of eggs in the diet. J Am Coll Nutr 2000;19:495S-8S.
2. Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114:82-96.
3. USDA and U.S. Department of Health and Human Services. Dietary guidelines for Americans. 7th ed. Washington: Government Printing Office; 2010.
4. Weggemans RM, Zock PL, Katan MB. Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis. Am J Clin Nutr 2001;73: 885-91.
5. Silbernagel G, Fauler G, Hoffmann MM, Lutjohann D, Winkelmann BR, Boehm BO, Marz W. The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality. J Lipid Res 2010;51:2384-93.
6. Herron KL, Lofgren IE, Sharman M, Volek JS, Fernandez ML. High intake of cholesterol results in less atherogenic low-density lipoprotein particles in men and women independent of response classification. Metabolism 2004;53:823-30.
7. Rong Y,Chen L,Zhu T, Song Y, Yu M, Shan Z, SandsA,Hu FB, Liu L. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ 2013;346:e8539.
8. Spence JD, Jenkins DJ, Davignon J. Egg yolk consumption and carotid plaque. Atherosclerosis 2012;224:469-73.
9. Kromhout D, Geleijnse JM, Menotti A, Jacobs DR, Jr. The confusion about dietary fatty acids recommendations for CHD prevention. Br J Nutr 2011;106:627-32.
10. Westerterp KR, Goris AH. Validity of the assessment of dietary intake: problems of misreporting. Curr Opin Clin Nutr Metab Care 2002;5:489-93.
11. Chung HY, Rasmussen HM, Johnson EJ. Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men. J Nutr 2004;134:1887-93.
12. Maiani G, Caston MJ, Catasta G, Toti E, Cambrodon IG, Bysted A, Granado-Lorencio F, Olmedilla-Alonso B, Knuthsen P, Valoti M, et al. Carotenoids: actual knowledge on food sources, intakes, stability and bioavailability and their protective role in humans. Mol Nutr Food Res 2009;53(Suppl 2):S194-218.
13. Wang W, Connor SL, Johnson EJ, Klein ML, Hughes S, Connor WE. Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration. Am J Clin Nutr 2007;85:762-9.
14. Kijlstra A, Tian Y, Kelly ER, Berendschot TT. Lutein: more than just a filter for blue light. Prog Retin Eye Res 2012;31:303-15.
15. Kim SR, Nakanishi K, Itagaki Y, Sparrow JR. Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp Eye Res 2006;82:828-39.
16. Neuringer M, Sandstrom MM, Johnson EJ, Snodderly DM. Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys. Invest Ophthalmol Vis Sci 2004;45:3234-43.
17. Prokofyeva E, Zrenner E. Epidemiology of major eye diseases leading to blindness in Europe: a literature review. Ophthalmic Res 2012;47:171-88.
18. Sabour-Pickett S, Nolan JM, Loughman J, Beatty S. A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration. Mol Nutr Food Res 2012;56:270-86.
19. Bosner MS, Ostlund RE, Jr., Osofisan O, Grosklos J, Fritschle C, Lange LG. Assessment of percent cholesterol absorption in humans with stable isotopes. J Lipid Res 1993;34:1047-53.
20. Miettinen TA, Gylling H, Strandberg T, Sarna S. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study. Finnish 4S Investigators. BMJ 1998;316:1127-30.
21. Thuluva SC, Igel M, Giesa U, Lutjohann D, Sudhop T, von Bergmann K. Ratio of lathosterol to campesterol in serum predicts the cholesterol lowering effect of sitostanol-supplemented margarine. Int J Clin Pharmacol Ther 2005;43:305-10.
22. Kesa¨niemi YA, Ehnholm C, Miettinen TA. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987;80:578-81.
23. Miettinen TA, Gylling H, Vanhanen H. Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet 1988;2:1261.
24. McKay GJ, Patterson CC, Chakravarthy U, Dasari S, Klaver CC, Vingerling JR, Ho L, de Jong PT, Fletcher AE, Young IS, et al. Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat 2011;32:1407-16.
25. Plat J, Mensink RP. Effects of diets enriched with two different plant stanol ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations. Metabolism 2001;50:520-9.
26. Mensink RP, de Jong A, Lutjohann D, Haenen GR, Plat J. Plant stanols dose-dependently decrease LDL-cholesterol concentrations, but not cholesterol-standardized fat-soluble antioxidant concentrations, at intakes up to 9 g/d. Am J Clin Nutr 2010;92:24-33.
27. Minihane AM, Jofre-Monseny L, Olano-Martin E, Rimbach G. ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation. Proc Nutr Soc 2007;66:183-97.
28. Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2008;115:334-41.
29. Age-Related Eye Disease Study 2 Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, et al. Lutein/zeaxanthin for the treatment of agerelated cataract: AREDS2 randomized trial report no. 4. JAMA Ophthalmol 2013;131:843-50.
30. Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J, van Norren D. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci 2000;41:3322-6.
31. Huang YM, Yan SF, Ma L, Zou ZY, Xu XR, Dou HL, Lin XM. Serum and macular responses to multiple xanthophyll supplements in patients with early age-related macular degeneration. Nutrition 2013;29: 387-92.
32. Handelman GJ, Nightingale ZD, Lichtenstein AH, Schaefer EJ, Blumberg JB. Lutein and zeaxanthin concentrations in plasma after dietary supplementation with egg yolk. Am J Clin Nutr 1999;70: 247-51.
33. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
34. Cholesterol Treatment Trialists_ Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-81.
35. Arsenault BJ, Rana JS, Stroes ES, Despres JP, Shah PK, Kastelein JJ, Wareham NJ, Boekholdt SM, Khaw KT. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/highdensity lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol 2009;55:35-41.
36. Blanco-Molina A, Castro G,Martin-Escalante D, Bravo D, Lopez-Miranda J, Castro P, Lopez-Segura F, Fruchart JC, Ordovas JM, Perez-Jimenez F. Effects of different dietary cholesterol concentrations on lipoprotein plasma concentrations and on cholesterol efflux from Fu5AH cells. Am J Clin Nutr 1998;68:1028-33.
37. Ginsberg HN, Karmally W, Siddiqui M, Holleran S, Tall AR, Blaner WS, Ramakrishnan R. Increases in dietary cholesterol are associated with modest increases in both LDL and HDL cholesterol in healthy young women. Arterioscler Thromb Vasc Biol 1995;15:169-78.
38. Ginsberg HN, Karmally W, Siddiqui M, Holleran S, Tall AR, Rumsey SC, Deckelbaum RJ, Blaner WS, Ramakrishnan R. A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler Thromb Vasc Biol 1994;14:576-86.
39. Herron KL, Vega-Lopez S, Conde K, Ramjiganesh T, Roy S, Shachter NS, Fernandez ML. Pre-menopausal women, classified as hypo- or hyperresponders, do not alter their LDL/HDL ratio following a high dietary cholesterol challenge. J Am Coll Nutr 2002;21:250-8.
40. Sacks FM, Salazar J, Miller L, Foster JM, Sutherland M, Samonds KW, Albers JJ, Kass EH. Ingestion of egg raises plasma low density lipoproteins in free-living subjects. Lancet 1984;1:647-9.
41. Baumgartner S, Kelly ER, van der Made S, Berendschot TT, Husche C, Lutjohann D, Plat J. The influence of consuming an egg or an egg-yolk buttermilk drink for 12 wk on serum lipids, inflammation, and liver function markers in human volunteers. Nutrition 2013;29:1237-44.
42. Duane WC. Serum lathosterol levels in human subjects reflect changes in whole body cholesterol synthesis induced by lovastatin but not dietary cholesterol. J Lipid Res 1995;36:343-8.
43. Zou Z, Xu X, Huang Y, Xiao X, Ma L, Sun T, Dong P, Wang X, Lin X. High serum level of lutein may be protective against early atherosclerosis: the Beijing atherosclerosis study. Atherosclerosis 2011;219: 789-93.
44. Plat J, Mensink RP. Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMG-CoA reductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption. Eur J Clin Invest 2002;32:242-50.